Coronary Restenosis - Etiology
Research News and Information

Monday, November 23, 2009

Upregulation of peroxisome proliferator-activated receptor-gamma and NADPH oxidases are involved in restenosis after balloon injury.

30 Oct 2009 Restenosis is a major complication of percutaneous transluminal coronary angioplasty (PTCA) and is characterized by increased superoxide formation and accumulation of smooth muscle cells (SMCs). The mechanisms through which peroxisome ... Read more...

Novel uses of the Proxis embolic protection catheter.

30 Aug 2009 The Proxis catheter has been designed for proximal embolic protection during saphenous vein graft interventions. The Proxis catheter's flexible and kink-resistant design, lubricity, and atraumatic tip allow deep seating in target vessels. We ... Read more...

Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.

30 Jul 2009 OBJECTIVES: The aim of this study was to compare the vessel response between zotarolimus-eluting stents (ZES) and paclitaxel-eluting stents (PES) using intravascular ultrasound. BACKGROUND: The ENDEAVOR IV (Randomized Comparison of Zotarolimus- and ... Read more...

Latest indexed articles for 'Coronary Restenosis - Etiology'

These are the very latest articles for this heading:

• Upregulation of peroxisome proliferator-activated receptor-gamma and NADPH oxidases are involved in restenosis after balloon injury. 30 Oct 2009
• Importance of creativity: new applications of the Proxis catheter. 30 Aug 2009
• Novel uses of the Proxis embolic protection catheter. 30 Aug 2009
• Images in cardiovascular medicine: Late abnormal vessel wall reaction 3 years after sirolimus-eluting stent implantation. 30 Aug 2009
• Stent underexpansion in early drug-eluting stent thrombosis. 30 Jul 2009
• Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease. 30 Jul 2009
• Angiographic restenosis and clinical recurrence after sirolimus- and paclitaxel-eluting stent implantation. 30 Jul 2009
• In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. 30 Jul 2009
• 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study. 30 Jul 2009
• Impact of timing on efficacy and safetyof intracoronary autologous bone marrow stem cells transplantation in acute myocardial infarction: a pooled subgroup analysis of randomized controlled trials. 30 Jul 2009
• Long-term clinical efficacy of cutting balloon angioplasty followed by bare metal stent implantation for treating ostial left anterior descending artery lesions. 30 Jul 2009
• Twelve months clinical outcome of drug-eluting stents implantation or coronary artery bypass surgery for the treatment of diabetic patients with multivessel disease. 30 Jul 2009
• Efficacy of cilostazol in reducing restenosis in patients undergoing contemporary stent based PCI: a meta-analysis of randomised controlled trials. 30 Jul 2009
• Angiographic and intravascular ultrasound findings following implantation of the Endeavor zotarolimus-eluting stents in patients from the real-world clinical practice. 30 Jul 2009
• Predictors of angiographic restenosis after drug eluting stents in the coronary arteries: contemporary practice in real world patients. 30 Jul 2009
• Biolimus-eluting biodegradable polymer versus sirolimus-eluting permanent polymer stent performance in long lesions: results from the LEADERS multicentre trial substudy. 30 Jul 2009
• Systematic reviews and meta-analyses "For Dummies". 30 Jul 2009
• The role of glucose lowering agents on restenosis after percutaneous coronary intervention in patients with diabetes mellitus. 26 Jul 2009
• Images in cardiovascular medicine. Thrombotic restenosis after minimally invasive implantation of aortic valve stent. 26 Jul 2009
• Different vascular response to concurrent implantation of sirolimus- and zotarolimus-eluting stents in the same vessel. 20 Jul 2009

See a longer list of these articles.

Technical information about 'Coronary Restenosis'

Definition: Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.

Descriptor UI: D023903

Alternative terms: Coronary Restenosis; Coronary Restenoses; Restenoses, Coronary; Restenosis, Coronary;

Allowable Qualifiers: drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology; blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy;

Tree Number: C14.280.647.250.285.200; C14.907.585.250.285.200;

History Note: 2002